About Biomedical Sciences

Click here for the latest Case Studies
Updated: 19 Nov 2007

Home > About Biomedical Sciences

	Asia is seeing rapid development in the biomedical sciences, with Singapore as the focal point of activities. In this city-state, world-class capabilities are being built across the entire value chain, from basic research, clinical development, product and process development, manufacturing to healthcare services.


	Advisory Committees Business Starting Up Kit Key Government Organisations Manufacturing Kit Research Institutes & Partners Research Highlights Why Singapore

1. Key Government Agencies

EDB's BMS group and Bio*One Capital, as well as A*STAR's BMRC work in close partnership. The goal is to develop the BMS cluster - comprising pharmaceuticals, medical technology, biotechnology and healthcare services - into a key pillar of the Singapore economy.

2. Basic & Clinical Research

Singapore has built strong capabilities in basic and clinical research and activities in this area have been growing significantly over the last decade.

3. Clinical Development

Singapore is ideal for clinical research and clinical trials management because of its consistent business environment, excellent communications infrastructure, highly skilled manpower, established regulatory infrastructure and strong IPR regime.

4. Product & Process Development

Many companies find that they are able to achieve shorter time-to-market from Singapore and thus compete globally.

5. Manufacturing

Biomedical manufacturing is enjoying strong growth in Singapore, with a significant 30.2% manufacturing output growth to S$23 billion in 2006. This growth will continue as global biomedical sciences companies set up or expand their manufacturing activities here.

6. Healthcare Services

A combination of excellent healthcare infrastructure, availability of skilled medical professional and latest medical technology has made Singapore the convincing healthcare services hub of Asia.

7. Business HQ

About 60 percent of the 7,000 multinational companies have decided to manage their regional operations from Singapore because of its global connectivity, world-class infrastructure, highly skilled workforce and pro-business environment.

8. Regulatory Framework

Singapore's regulatory and intellectual property protection infrastructure is acutely attuned for pharmaceutical and medical technology companies to leverage on for their R&D activities.

9. Infrastructure

The only location in Asia that offers a world-class physical infrastructure, an outstanding research infrastructure backed by established supporting industries.

10. Milestones

Chronological listing of the major developments in biomedical sciences over the past two decades in Singapore.

Search